Islamabad, Pakistan
Reuters
One case of the mpox virus has been detected in Pakistan of the clade 2 variety, the country’s ministry of health said on Monday, adding that no cases of the clade 1b strain of the disease have been diagnosed.
Clade 1b has triggered global concern because it seems to spread more easily though routine close contact. A case of the variant was confirmed last week in Sweden and linked to a growing outbreak in Africa, the first sign of its spread outside the continent
An undated colorized scanning electron micrograph of mpox virus (red) on the surface of infected VERO E6 cells (green), captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. PICTURE: NIAID/Handout via Reuters/File photo
“As of now, there have been no reported cases of clade I in Pakistan,” said Sajid Hussain Shah, spokesman for the ministry of national health services.
The World Health Organization declared the recent outbreak of the disease a public health emergency of international concern after the new variant was identified.
The WHO last week sounded its highest level of alert over the outbreak in Africa after cases in the Democratic Republic of Congo spread to nearby countries. There have been 27,000 cases and more than 1,100 deaths, mainly among children, in the DRC since the current outbreak began in January 2023.
Global health officials on last week confirmed an infection with the new strain of mpox in Sweden and linked it to a growing outbreak in Africa, the first sign of its spread outside the continent. The WHO did not urge any travel restrictions to curb the spread of mpox.
Meanwhile, the Democratic Republic of the Congo hopes to receive its first doses of an mpox vaccine by next week, following promises from the United States and Japan to help it fight its outbreak, the Congolese health minister said on Monday.
The World Health Organization last week declared mpox a global public health emergency for the second time in two years as a new variant of the disease, known as clade Ib, spread rapidly in Africa.
In a news conference on Monday, Health Minister Samuel Roger Kamba Mulamba said that Japan and the United States had pledged vaccines to Congo.
“We’ve just finished discussions with USAID and the US Government…I hope that by next week we’ll be able to see the vaccines arrive,” he told reporters.
We rely on our readers to fund Sight's work - become a financial supporter today!
For more information, head to our Subscriber's page.
Their arrival would help to address a huge inequity that left African countries with no access to the two shots used in a 2022 global mpox outbreak, while the vaccines were widely available in Europe and the United States.
Earlier on Monday, Japan’s Ministry of Health, Labour and Welfare said in an emailed statement to Reuters that it was preparing to provide Congo with supplies of mpox vaccines and needles in cooperation with the World Health Organization and other partners.
The ministry “intends to provide as much support as possible”, Masano Tsuzuki, section chief of its division of infectious disease prevention and control, said.
Japan-based KM Biologics is one of the manufacturers of an mpox vaccine. Denmark’s Bavarian Nordic makes another vaccine, called Jynneos, for the disease. Japan holds a stockpile of the KM Biologics vaccine.
Outside clinical trials, neither of the shots have been available in Congo or across Africa, where the disease has been endemic for decades.
The global vaccine group Gavi said last week it had up to $US500 million to spend on getting shots to countries affected by Africa’s escalating mpox outbreak.
“Gavi has offered to make the vaccines available and we agreed,” Congo’s health minister said.
Mpox, a viral infection that causes pus-filled lesions and flu-like symptoms, is usually mild but can kill. Two strains are spreading in Congo – the endemic form of the virus, clade I, and the new clade Ib offshoot.
The virus transmits through close physical contact, including sexual contact, but unlike previous global pandemics such as COVID-19, there is no evidence it spreads easily through the air.
– With reporting by CHRISTY SANTHOSH in Bengaluru, India; ROCKY SWIFT in Tokyo, Japan; and ANGE KASONGO and BENOIT NYEMBA in Kinshasa, Democratic Republic of Congo.
